ATLASContineum Therapeutics (CTNM) earnings date: expected January 20–26
Contineum Therapeutics (CTNM) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 20–26. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CTNM
| Last price | $9.39 (+0.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.4% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Contineum Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 20–26 (estimate). One email the day before, with ATLAS’s read on Contineum Therapeutics. You can switch it off at any time.
Alert me before CTNM reportsFree to start. Creating an account takes under a minute.
CTNM earnings at a glance
| Next report | Not announced · expected around January 20–26 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +9.7% |
| Average move around a report | ±4.9% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Contineum Therapeutics’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Contineum Therapeutics earnings history: last 6 reports
Contineum Therapeutics last reported on Oct 29, 2026: EPS of -$0.45 against an estimate of -$0.45.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.45 | -$0.45 | – | – | – |
| Jul 30, 2026 | -$0.45 | -$0.40 | +11.1% | Beat | +7.7% |
| May 5, 2026 | -$0.53 | -$0.39 | +26.4% | Beat | +5.6% |
| Mar 16, 2026 | $2.01 | $2.62 | +30.3% | Beat | +1.7% |
| Mar 5, 2026 | -$0.39 | -$0.49 | -25.6% | Miss | -6.6% |
| Feb 26, 2026 | $0.32 | $0.34 | +6.3% | Beat | -2.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CTNM
See the fair value, the probability range and the earnings history of Contineum Therapeutics on its ATLAS page.
Contineum Therapeutics (CTNM) stock analysisPlans from €3.99 a month.
Contineum Therapeutics earnings: frequently asked questions
When is Contineum Therapeutics (CTNM) next earnings date?
Contineum Therapeutics has not announced its next report. Its last 4 reports came Oct 29, 2026, Jul 30, 2026, May 5, 2026, Mar 5, 2026, so ATLAS estimates the next one around January 20–26. This is an estimate based on that pattern, not a confirmed date.
How often does CTNM beat earnings estimates?
Of its last 5 reports with a recorded result, Contineum Therapeutics beat the EPS estimate 4 times; the average surprise was +9.7%. Past results do not predict the next one.
How much does CTNM move around earnings?
Over its last 5 reports the stock moved an average of 4.9% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Contineum Therapeutics beat earnings estimates last quarter?
Contineum Therapeutics last reported on Oct 29, 2026: EPS of -$0.45 against an estimate of -$0.45.
How much does CTNM usually move in a day?
On a normal trading day the ATLAS model puts CTNM’s one-day range at about ±7.4%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer